Literature DB >> 2925007

Proliferative retinopathy in NIDDM. Incidence and risk factors in Pima Indians.

R G Nelson1, J A Wolfe, M B Horton, D J Pettitt, P H Bennett, W C Knowler.   

Abstract

The incidence of proliferative diabetic retinopathy was determined in the Pima Indians of the Gila River Indian Community in Arizona. Over 4 yr, this complication developed in 25 of 953 subjects greater than or equal to 9 yr of age with non-insulin-dependent diabetes. No cases were diagnosed in less than 35-yr-old subjects, and the incidence was strongly related to the duration of diabetes. The cumulative incidence of proliferative retinopathy after 20 yr duration was 14%. All cases of proliferative retinopathy occurred in subjects with background retinopathy. Younger age at diagnosis of diabetes was associated with a higher incidence of proliferation when subjects with diabetes of similar duration were compared. A higher incidence of proliferative retinopathy, after controlling for age, sex, and diabetes duration, was associated with hypertension, proteinuria, renal insufficiency, absence of Achilles tendon reflex, elevated total serum cholesterol concentration, and insulin therapy.

Entities:  

Mesh:

Year:  1989        PMID: 2925007     DOI: 10.2337/diab.38.4.435

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  9 in total

1.  Prevalence of diabetic retinopathy in patients with diabetes mellitus diagnosed after the age of 70 years.

Authors:  M Cahill; A Halley; M Codd; N O'Meara; R Firth; D Mooney; R W Acheson
Journal:  Br J Ophthalmol       Date:  1997-03       Impact factor: 4.638

Review 2.  Diabetes mellitus.

Authors:  A B Johnson; R Taylor
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

Review 3.  Obesity and eye diseases.

Authors:  Ning Cheung; Tien Y Wong
Journal:  Surv Ophthalmol       Date:  2007 Mar-Apr       Impact factor: 6.048

4.  Hemoglobin A1c and fasting plasma glucose levels as predictors of retinopathy at 10 years: the French DESIR study.

Authors:  Pascale Massin; Céline Lange; Jean Tichet; Sylviane Vol; Ali Erginay; Martine Cailleau; Eveline Eschwège; Beverley Balkau
Journal:  Arch Ophthalmol       Date:  2011-02

5.  Glycated haemoglobin, plasma glucose and diabetic retinopathy: cross-sectional and prospective analyses.

Authors:  Q Z Liu; D J Pettitt; R L Hanson; M A Charles; R Klein; P H Bennett; W C Knowler
Journal:  Diabetologia       Date:  1993-05       Impact factor: 10.122

Review 6.  Update on Youth-Onset Type 2 Diabetes: Lessons Learned from the Treatment Options for Type 2 Diabetes in Adolescents and Youth Clinical Trial.

Authors:  Rachelle Gandica; Phil Zeitler
Journal:  Adv Pediatr       Date:  2016-06-03

7.  Determinants of end-stage renal disease in Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus and proteinuria.

Authors:  R G Nelson; W C Knowler; D R McCance; M L Sievers; D J Pettitt; M A Charles; R L Hanson; Q Z Liu; P H Bennett
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

8.  Renal function but not asymmetric dimethylarginine is independently associated with retinopathy in type 2 diabetes.

Authors:  Katarzyna Krzyzanowska; Friedrich Mittermayer; Gerit H Schernthaner; Simon Brunner; Johanna M Brix; Stefan Aschauer; Florian Höllerl; Michael Wolzt; Guntram Schernthaner
Journal:  Cardiol Res Pract       Date:  2011-05-09       Impact factor: 1.866

9.  Black patients sustain vision loss while White and South Asian patients gain vision following delamination or segmentation surgery for tractional complications associated with proliferative diabetic retinopathy.

Authors:  R Mastropasqua; Y H-L Luo; Y S Cheah; C Egan; J J Lewis; L da Cruz
Journal:  Eye (Lond)       Date:  2017-06-02       Impact factor: 3.775

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.